Research Study

QUEST: QUadrivalent Hpv vaccine Evaluation STudy
Principal Investigator 
Simon Dobson

Overview

Body Locations and Systems 
Disorders and Conditions 
Status 
Recruiting
Study Start/End 
Jan 1, 2012 to Oct 30, 2022
Locations 
Vancouver Community
Name/Title 
Ashley Cosgrove, Communications Manager
Phone 
604-875-2860
Email Address 
acosgrove@cfri.ca
Purpose of Study 

QUEST (Quadrivalent HPV Vaccine Evaluation Study) is a Canada-wide study designed to evaluate whether 2 doses of the HPV vaccine are just as effective as 3 doses at preventing Human Papillomavirus (HPV) infection and cervical cancer.

Eligibility 

Inclusion Criteria:

  • The QUEST study will seek to recruit teenage girls from across B.C. who will range in age from about 12 to 17.  Girls can take part in this study if they have received 3 doses of the HPV vaccine.
Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.